keyword
https://read.qxmd.com/read/38355266/p2y-12-inhibitors-in-chronic-coronary-syndromes-undergoing-elective-pci-any-niche-for-potent-agents
#21
EDITORIAL
José Luis Ferreiro
No abstract text is available yet for this article.
February 12, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38347539/characterization-of-two-distinct-immortalized-endothelial-cell-lines-ea-hy926-and-hmec-1-for-in-vitro-studies-exploring-the-impact-of-calcium-electroporation-ca-2-signaling-and-transcriptomic-profiles
#22
JOURNAL ARTICLE
Barbara Lisec, Tim Bozic, Iva Santek, Bostjan Markelc, Milka Vrecl, Robert Frangez, Maja Cemazar
BACKGROUND: Disruption of Ca2+ homeostasis after calcium electroporation (CaEP) in tumors has been shown to elicit an enhanced antitumor effect with varying impacts on healthy tissue, such as endothelium. Therefore, our study aimed to determine differences in Ca2+  kinetics and gene expression involved in the regulation of Ca2+  signaling and homeostasis, as well as effects of CaEP on cytoskeleton and adherens junctions of the established endothelial cell lines EA.hy926 and HMEC-1...
February 12, 2024: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/38265853/correction-to-age-related-changes-in-p2y-receptor-signalling-in-mouse-cochlear-supporting-cells
#23
(no author information available yet)
No abstract text is available yet for this article.
January 24, 2024: Journal of Physiology
https://read.qxmd.com/read/38246724/the-role-of-p2y-6-receptor-in-the-pathogenesis-of-cardiovascular-and-inflammatory-diseases
#24
REVIEW
Kazuhiro Nishiyama
The purinergic receptor P2Y6 receptor (P2Y6 R) is a member of the G protein-coupled receptors (GPCR) family. P2Y6 R is widely expressed in various cell types and plays a critical role in physiological processes, where it is activated by extracellular uridine diphosphate (UDP) and mobilizes Ca2+ via the Gαq/11 protein pathway. We have recently discovered the pathophysiological role of P2Y6 R in cardiovascular and inflammatory diseases, including inflammatory bowel disease and non-alcoholic fatty liver disease...
February 2024: Journal of Pharmacological Sciences
https://read.qxmd.com/read/38241058/platelet-reactivity-and-activated-clotting-time-predict-hemorrhagic-site-complications-in-patients-with-chronic-coronary-syndromes-undergoing-percutaneous-coronary-interventions
#25
JOURNAL ARTICLE
Bogumił Ramotowski, Paweł Lewandowski, Tomasz Słomski, Paweł Maciejewski, Andrzej Budaj
BACKGROUND: Radial access is preferred in patients with chronic coronary syndromes (CCSs) treated with ad hoc percutaneous coronary intervention (PCI). Antithrombotic and antiplatelet treatment before PCI may affect outcomes at vascular access sites. QuikClot Radial is a kaolin-based band that may shorten hemostasis time. Using point-of-care testing, we investigated the effect of antithrombotic and antiplatelet treatment on access-site complications. METHODS: This prospective observational study included consecutive patients with CCS on chronic aspirin therapy referred for ad hoc PCI...
January 22, 2024: Coronary Artery Disease
https://read.qxmd.com/read/38233328/net-adverse-clinical-events-with-p2y-12-inhibitor-therapy-in-older-patients-after-percutaneous-coronary-interventions
#26
EDITORIAL
Edina Cenko, Olivia Manfrini, Raffaele Bugiardini
No abstract text is available yet for this article.
December 27, 2023: Atherosclerosis
https://read.qxmd.com/read/38202070/platelet-micrornas-as-potential-novel-biomarkers-for-antiplatelet-therapy-with-p2y-12-inhibitors-and-their-association-with-platelet-function
#27
JOURNAL ARTICLE
Karolina Gumiężna, Adrian Bednarek, Grażyna Sygitowicz, Agata Maciejak-Jastrzębska, Piotr Baruś, Jaromir Hunia, Dominika Klimczak-Tomaniak, Janusz Kochman, Marcin Grabowski, Mariusz Tomaniak
INTRODUCTION: Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) require dual antiplatelet therapy (DAPT). However, the response to treatment can vary considerably. Certain platelet microRNAs (miRs) are suspected to predict DAPT response and influence platelet function. This study aimed to analyze selected miRs' expressions and compare them among patients treated with different P2Y12 inhibitors while assessing their association with platelet activity and turnover parameters...
December 22, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38199750/pretreating-with-p2y-12-inhibitors-in%C3%A2-stemi-does-it-make-any-difference
#28
EDITORIAL
George A Stouffer, Kevin A Friede, Joseph S Rossi
No abstract text is available yet for this article.
January 8, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38199749/pretreatment-with-p2y-12-inhibitors-in%C3%A2-st-segment-elevation-myocardial%C3%A2-infarction-insights-from-the-bern-pci-registry
#29
JOURNAL ARTICLE
Miklos Rohla, Shirley Xinyu Ye, Hiroki Shibutani, Jolie Bruno, Tatsuhiko Otsuka, Jonas D Häner, Sarah Bär, Fabrice Temperli, Raminta Kavaliauskaite, Jonas Lanz, Stefan Stortecky, Fabien Praz, Lukas Hunziker, Thomas Pilgrim, George Cm Siontis, Sylvain Losdat, Stephan Windecker, Lorenz Räber
BACKGROUND: Evidence to support immediate P2Y12 inhibitor loading in ST-segment elevation myocardial infarction (STEMI) is limited. OBJECTIVES: This study sought to compare outcomes of STEMI patients receiving immediate or delayed P2Y12 inhibitor treatment. METHODS: Using data from the prospective Bern-PCI registry between 2016 and 2020, we stratified STEMI patients undergoing percutaneous coronary intervention according to time periods with different institutional recommendations regarding P2Y12 inhibitor pretreatment...
January 8, 2024: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38191294/the-p2y-1-receptor-in-the-colonic-myenteric-plexus-of-rats-and-its-correlation-with-opioid-induced-constipation
#30
JOURNAL ARTICLE
Yuqiong Zhao, Huijuan Luo, Xiaojie Ren, Binghan Jia, Jinzhao Li, Lixin Wang, Junping Li
This study was designed to explore the expression changes of P2Y1 receptors in the distal colonic myenteric layer of rats. An opioid induced constipation(OIC) rat model was generated by intraperitoneal (i.p) injection of loperamide. At 7 days post-treatment, the model rats were assessed by calculating the fecal water content and the gastrointestinal transit ratio. The immunofluorescence (IF)-based histochemical study was used to observe the distribution of P2Y1 receptors in the distal colonic myenteric plexus...
January 8, 2024: BMC Gastroenterology
https://read.qxmd.com/read/38153612/p2-purinergic-receptors-regulate-the-progression-of-colorectal-cancer
#31
REVIEW
Wen-Jun Zhang, Li-Peng Zhang, Si-Jian Lin, Cheng-Yi Wang, Yi-Guan Lei
More and more studies have revealed that P2 purinergic receptors play a key role in the progression of colorectal cancer (CRC). P2X and P2Y purinergic receptors can be used as promoters and regulators of CRC and play a dual role in the progression of CRC. CRC microenvironment is rich in ATP and its cleavage products (ADP, AMP, Ado), which act as activators of P2X and P2Y purinergic receptors. The activation of P2X and P2Y purinergic receptors regulates the progression of CRC mainly by regulating the function of immune cells and mediating different signal pathways...
December 28, 2023: Purinergic Signalling
https://read.qxmd.com/read/38152569/preliminary-data-from-a-4-year-mirror-image-and-multicentre-study-of-patients-initiating-paliperidone-palmitate-6-monthly-long-acting-injectable-antipsychotic-the-paliperidone-2-per-year-study
#32
JOURNAL ARTICLE
Juan Antonio García-Carmona, Alba García-Pérez, Guillermo Isidro García, Luis Alberto Forcen-Muñoz, Santiago Ovejero García, Rocío Sáez Povedano, Ana Luisa González-Galdámez, Laura Mata Iturralde, Fernando Hernández-Sánchez, Mariluz Ramirez Bonilla, Paloma Fuentes-Pérez, Claudia Ovejas-Catalán, Paula Suárez-Pinilla, Francisco Valdivia-Muñoz, Blanca Fernández Abascal, Miguel Omaña Colmenares, Ángela de Lourdes Martín-Pérez, María Pilar Campos-Navarro, Enrique Baca-García, Sergio Benavente-López, Alberto Raya Platero, Miguel Barberán Navalón, Sergio Sánchez-Alonso, Javier Vázquez-Bourgon, Sofia Pappa
BACKGROUND: Paliperidone palmitate 6-monthly (PP6M) is the first long-acting antipsychotic injectable (LAI) to allow for only two medication administrations per year, though there is presently limited insight into its effectiveness and potential added value in real clinical practice conditions. OBJECTIVES: To present our ongoing study and draw its preliminary data on patient characteristics initiating PP6M and adherence during the first year of treatment. METHODS: The paliperidone 2 per year (P2Y) study is a 4-year, multicentre, prospective mirror-image pragmatic study taking place at over 20 different sites in Europe...
2023: Therapeutic Advances in Psychopharmacology
https://read.qxmd.com/read/38151691/cell-cycle-regulation-by-adp-and-igf-1-in-cultured-late-developing-glia-progenitors-of-the-avian-retina
#33
JOURNAL ARTICLE
Isis Moraes Ornelas, Thayane Martins Silva, Mariana Rodrigues Pereira, Guilherme Rapozeiro França, Ana Lucia Marques Ventura
In the avian retina, ADP induces the proliferation of late developing glia progenitors. Here, we show that in serum-containing retinal cell cultures, ADP-induced increase in [3 H]-thymidine incorporation can be prevented by the IGF-1 receptor antagonists AG1024 and I-OMe-Tyrphostin AG 538, suggesting the participation of IGF-1 in ADP-mediated progenitor proliferation. In contrast, no increase in [3 H]-thymidine incorporation is observed in retinal cultures treated only with IGF-1. Under serum starvation, while no increase in cell proliferation is detected in cultures treated only with ADP or IGF-1, a significant increase in [3 H]-thymidine incorporation and number of PCNA expressing cells is observed in cultures treated concomitantly with ADP plus IGF-1, suggesting that both molecules are required to induce proliferation of retinal progenitors...
December 27, 2023: Purinergic Signalling
https://read.qxmd.com/read/38142931/p2y-13-receptor-involved-in-hiv-1-gp120-induced-neuropathy-in-superior-cervical-ganglia-through-nlrp3-inflammasome-activation
#34
REVIEW
Sui Yin, Xuexuan Yang, Honglei Li, Chenxi Li, Changyi Li, Chengxu Chen, Shang Ye, Lifang Zou, Shangdong Liang, Shuangmei Liu
Cardiac autonomic neuropathy resulting from human immunodeficiency virus (HIV) infection is common; however, its mechanism remains unknown. The current work attempted to explore the function and mechanism of the P2Y13 receptor in HIV-glycoprotein 120 (gp120)-induced neuropathy in cervical sympathetic ganglion. The superior cervical ganglion (SCG) of the male SD rat was coated with HIV-gp120 to establish a model of autonomic neuropathy. In each group, we measured heart rate, blood pressure, heart rate variability, sympathetic nerve discharge and cardiac function...
December 22, 2023: Neuropharmacology
https://read.qxmd.com/read/38141758/the-p2y2-receptor-mediates-terminal-adipocyte-differentiation-and-insulin-resistance-evidence-for-a-dual-g-protein-coupling-mode
#35
JOURNAL ARTICLE
Shenqi Qian, Yi Shi, Jared Senfeld, Qianman Peng, Jianzhong Shen
Several P2Y nucleotide receptors have been shown to be involved in the early stage of adipocyte differentiation in vitro and insulin resistance in obese mice; however, the exact receptor subtype(s) and its underlying molecular mechanism in relevant human cells are unclear. Here, using human primary visceral preadipocytes as a model, we found that during preadipocyte-to-mature adipocyte differentiation, the P2Y2 nucleotide receptor (P2Y2R) was the most upregulated subtype among the eight known P2Y receptors and the only one further dramatically upregulated after inflammatory TNFα treatment...
December 21, 2023: Journal of Biological Chemistry
https://read.qxmd.com/read/38139810/pharmacological-nature-of-the-purinergic-p2y-receptor-subtypes-that-participate-in-the-blood-pressure-changes-produced-by-adp%C3%AE-s-in-rats
#36
JOURNAL ARTICLE
Roberto C Silva-Velasco, Belinda Villanueva-Castillo, Kristian A Haanes, Antoinette MaassenVanDenBrink, Carlos M Villalón
Purine nucleosides (adenosine) and nucleotides such as adenosine mono/di/triphosphate (AMP/ADP/ATP) may produce complex cardiovascular responses. For example, adenosine-5'-(β-thio)-diphosphate (ADPβS; a stable synthetic analogue of ADP) can induce vasodilatation/vasodepressor responses by endothelium-dependent and independent mechanisms involving purinergic P2Y receptors; however, the specific subtypes participating in these responses remain unknown. Therefore, this study investigated the receptor subtypes mediating the blood pressure changes induced by intravenous bolus of ADPβS in male Wistar rats in the absence and presence of central mechanisms with the antagonists MRS2500 (P2Y1 ), PSB0739 (P2Y12 ), and MRS2211 (P2Y13 )...
December 3, 2023: Pharmaceuticals
https://read.qxmd.com/read/38079109/p2y6-receptor-activation-aggravates-nlrp3-dependent-microglial-pyroptosis-via-downregulation-of-the-pi3k-akt-pathway-in-a-mouse-model-of-intracerebral-hemorrhage
#37
JOURNAL ARTICLE
Yulong Li, Huiru Tu, Shengfan Zhang, Zhiquan Ding, Guiwei Wu, Jifeng Piao, Dingyi Lv, Libin Hu, Feng Li, Qinghua Wang
Pro-inflammatory signals generated after intracerebral hemorrhage (ICH) trigger a form of regulated cell death known as pyroptosis in microglia. White matter injury (WMI) refers to the condition where the white matter area of the brain suffers from mechanical, ischemic, metabolic, or inflammatory damage. Although the p2Y purinoceptor 6 (P2Y6R) plays a significant role in the control of inflammatory reactions in central nervous system diseases, its roles in the development of microglial pyroptosis and WMI following ICH remain unclear...
December 11, 2023: Molecular Neurobiology
https://read.qxmd.com/read/37987757/the-distribution-of-purinergic-receptors-p2y-and-p2x-expression-within-the-intestine
#38
JOURNAL ARTICLE
Kristen A Engevik, Francesca J Scribano, J Thomas Gebert, Jacob L Perry, Sue E Crawford, Joseph M Hyser
Nucleotides are potent extracellular signaling molecules during homeostasis, infection, and injury due to their ability to activate purinergic receptors. The nucleotide ATP activates P2X receptors (P2RXs), while the nucleotides ADP, ATP, UTP and UDP-glucose selectively activate different P2Y receptors (P2RYs). Several studies have established crucial roles for P2 receptors during intestinal inflammatory and infectious diseases, yet the most extensive characterization of purinergic signaling has focused on immune cells and the central and enteric nervous systems...
November 21, 2023: American Journal of Physiology. Gastrointestinal and Liver Physiology
https://read.qxmd.com/read/37962571/coronary-no-reflow-and-adverse-events-in-patients-with-acute-myocardial-infarction-after-percutaneous-coronary-intervention-with-current-drug-eluting-stents-and-third-generation-p2y-12-inhibitors
#39
JOURNAL ARTICLE
Gjin Ndrepepa, Salvatore Cassese, Erion Xhepa, Michael Joner, Hendrik B Sager, Sebastian Kufner, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati
BACKGROUND: The frequency and prognostic value of coronary no-reflow (CNR) was investigated in studies that have used an outdated reperfusion therapy in terms of stent technology and antithrombotic drugs. We assessed the association of CNR with adverse outcomes in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) and newer antithrombotic drugs, ticagrelor or prasugrel. METHODS: This study included 3100 patients with AMI who underwent PCI with current DES and third-generation P2Y12 inhibitors...
November 14, 2023: Clinical Research in Cardiology: Official Journal of the German Cardiac Society
https://read.qxmd.com/read/37955640/identification-of-a-carbohydrate-recognition-motif-of-purinergic-receptors
#40
JOURNAL ARTICLE
Lifen Zhao, Fangyu Wei, Xinheng He, Antao Dai, Dehua Yang, Hualiang Jiang, Liuqing Wen, Xi Cheng
As a major class of biomolecules, carbohydrates play indispensable roles in various biological processes. However, it remains largely unknown how carbohydrates directly modulate important drug targets, such as G-protein coupled receptors (GPCRs). Here, we employed P2Y purinoceptor 14 (P2Y14), a drug target for inflammation and immune responses, to uncover the sugar nucleotide activation of GPCRs. Integrating molecular dynamics simulation with functional study, we identified the uridine diphosphate (UDP)-sugar-binding site on P2Y14, and revealed that a UDP-glucose might activate the receptor by bridging the transmembrane (TM) helices 2 and 7...
November 13, 2023: ELife
keyword
keyword
163872
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.